Mannkind (MNKD) Profit After Tax (2010 - 2026)
Mannkind (MNKD) reported Profit After Tax of -$16.6 million for Q1 2026, down 226.3% year-over-year from $13.2 million in Q1 2025, and down 4.21% quarter-over-quarter from -$15.9 million in Q4 2025.
Mannkind (MNKD) Profit After Tax (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Profit After Tax data on file, last reported at -$16.6 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$16.6 million, down 226.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$23.9 million (down 179.41% YoY), and the FY2025 annual result was $5.9 million, down 78.75% from the prior year.
- Profit After Tax fell to -$16.6 million in Q1 2026 per MNKD's latest filing, from -$15.9 million in the prior quarter.
- Over five years, Profit After Tax peaked at $13.2 million in Q1 2025 and troughed at -$29.0 million in Q2 2022.
- A 5-year average of -$4.9 million and a median of -$2.0 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax surged 571.12% in 2024, then plunged 314.87% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$17.9 million in 2022, then soared by 107.81% to $1.4 million in 2023, then soared by 429.76% to $7.4 million in 2024, then tumbled by 314.87% to -$15.9 million in 2025, then slipped by 4.21% to -$16.6 million in 2026.
- Business Quant data shows MNKD's Profit After Tax at -$16.6 million in Q1 2026, -$15.9 million in Q4 2025, and $8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.74 Mn |
| 10 | Mannkind | 1.13 Bn | 995.19 Mn | 82.66 Mn | -16.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.62 Mn |
| Dec 31, 2025 | -15.95 Mn |
| Sep 30, 2025 | 7.99 Mn |
| Jun 30, 2025 | 668,000.00 |
| Mar 31, 2025 | 13.16 Mn |
| Dec 31, 2024 | 7.42 Mn |
| Sep 30, 2024 | 11.55 Mn |
| Jun 30, 2024 | -2.01 Mn |
| Mar 31, 2024 | 10.63 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | -5.27 Mn |
| Mar 31, 2023 | -9.80 Mn |
| Dec 31, 2022 | -17.95 Mn |
| Sep 30, 2022 | -14.43 Mn |
| Jun 30, 2022 | -29.02 Mn |
| Mar 31, 2022 | -26.00 Mn |
| Dec 31, 2021 | -28.06 Mn |
| Sep 30, 2021 | -4.43 Mn |
| Jun 30, 2021 | -35.52 Mn |